No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats (Q48375807)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 1998

Language	Label	Description	Also known as
English	No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats	scientific article published in September 1998

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9774242

No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9774242

Pekka T. Männistö

6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9774242

author name string

Y H Li

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9774242

T Wirth

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9774242

M Huotari

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9774242

K Laitinen

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9774242

E MacDonald

5

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9774242

language of work or name

0 references

publication date

1 September 1998

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9774242

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9774242

356

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9774242

2-3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9774242

127-137

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9774242

Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Effect of chloral hydrate on in vivo KCl-induced striatal dopamine release in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

The pharmacology of Parkinson's disease: basic aspects and recent advances

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Effects of monoamine oxidase and catechol-O-methyltransferase inhibition on dopamine turnover: a PET study with 6-[18F]L-DOPA.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Anaesthetic effects of chloral hydrate, pentobarbitone and urethane in adult male rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

S-adenosyl-L-methionine. A review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Striatal extracellular dopamine in conscious vs. anesthetized rats: effects of chloral hydrate anesthetic on responses to drugs of different classes

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Effects of catechol-O-methyltransferase inhibitors and L-3,4-dihydroxyphenylalanine with or without carbidopa on extracellular dopamine in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Ascending afferent regulation of rat midbrain dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Effects of selective catechol-O-methyltransferase inhibitors on single-trial passive avoidance retention in male rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Cholinergic-dopaminergic interactions in cognitive performance

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Catechol O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Behavioural and neurochemical effects of medetomidine, a novel veterinary sedative

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Catechol O-methyltransferase: characterization of the protein, its gene, and the preclinical pharmacology of COMT inhibitors

2 references

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effects of co-administration of catechol-O-methyltransferase inhibitors and L-dihydroxyphenylalanine in rat models of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Application of high performance liquid chromatography with electrochemical detection to neurochemical analysis: measurement of catecholamines, serotonin and metabolites in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Anesthetics decreased the microdialysis extraction fraction of norepinephrine but not dopamine in the medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Physical and chemical considerations in the in vitro calibration of microdialysis probes for biogenic amine neurotransmitters and metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Catechol-O-methyltransferase activity: a determinant of levodopa response.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Comparison of free MHPG in rat cerebrospinal fluid with free and conjugated MHPG in brain tissue: effects of drugs modifying noradrenergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Antioxidant properties of nitecapone (OR-462)

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Comparison of two new inhibitors of catechol O-methylation on striatal dopamine metabolism: a microdialysis study in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Minor effect of tolcapone, a catechol-O-methyltransferase inhibitor, on extracellular dopamine levels modified by amphetamine or pargyline: a microdialysis study in anaesthetized rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

Excitation of striatal neurons by dexamphetamine is not abolished by either chloral hydrate or urethane anaesthesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900524-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0014-2999(98)00524-X

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9774242

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9774242

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48375807&oldid=2196384827"